Significance of combined Use of Neutrophil GelatinaseAssociated Lipocalin and Natriuretic Peptides for Diagnosis and Follow up of Patients with Chronic Kidney Diseases
Keywords:
Natriuretic peptides, Neutrophil gelatin-associated lipocalin, chronic kidney diseases, renal failure.Abstract
Natriuretic peptides (NPs), are a structurally related group of hormones or paracrine factors sharing a common function of increasing renal sodium excretion and, consequently, reducing expanded extracellular volume. The principal NPs in clinical use are NT-pro BNP and NT-pro CNP. There is some evidence that using NPs tests in emergency departments could replace many expensive tests, and shorten the hospital stay and cost of treatment. Objectives: To identify the significance of using NPs and NGAL for the diagnosis and/or follow-up of subjects with chronic kidney diseases (CKD) in comparison with routinely used markers. This study involved 78 participants: 38 controls (seemingly healthy normal adults) and 40 CKD patients. They were 50.6 9.3 and 52.4 8.8 years old on average, respectively. NPs and NGAL were assessed by enzyme-linked immunosorbent assays, while assessments of renal function and serum electrolytes were performed by conventional available laboratory procedures. There was a significant increase in NT-pro CPN, NT-pro BNP, and NGAL in the patient group compared to the control group. To discriminate between CKD and controls the ROC curve revealed excellent sensitivity and specificity after using the NGAL (90% and 100%, respectively; at a 78.5 ng/ml cutoff value). The sensitivity of NT-pro CNP and specificity were 82% and 90%, respectively, at a 4.95 pg/ml limit value. While the sensitivity of NT-pro BNP and specificity were 72% and 68%, respectively at a 565 pg/ml threshold. Significant positive direct correlations existed between serum creatinine with each of NGAL and NT-pro BNP.
Downloads
References
Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007 Dec 18;50(25):2357-68. doi: 10.1016/j.jacc.2007.09.021
Arnold R, Issar T, Krishnan AV, Pussell BA. Neurological
complications in chronic kidney disease. JRSM Cardiovasc Dis.
; 5:2048004016677687. doi:10.1177/2048004016677687
Couser WG, Remuzzi G, Mendis S, et al. The contribution of chronic
kidney disease to the global burden of major noncommunicable
diseases. Kidney Int 2011; 80: 1258-1270.
Wasung ME, Chawla LS, Madero M. Biomarkers of renal function,
which and when? Clin Chim Acta. 2015 Jan 1; 438:350-7. doi:
1016/j.cca.2014.08.039.
Adnan A. Al-Bdairi, Hanan KH Al-kadhim, Suhaila F. Al-Shaikh. ABO
Blood grouping
and Rhesus factor: Association with ovarian reserve and the outcomes
after in-vitro
fertilization. History of Medicine, 2022, 8(1): 18-28.
Rysz J, Gluba-Brzozka A, Franczyk B, Jablonowski Z, Cialkowska-Rysz
A. Novel Biomarkers in the Diagnosis of Chronic Kidney Disease
and the Prediction of Its Outcome. Int J Mol Sci. 2017 Aug
;18(8):1702. doi: 10.3390/ijmsl8081702. PMID: 28777303;
PMCID: PMC5578092.
Zhang WR, Parikh CR. Biomarkers of Acute and Chronic Kidney
Disease. Annu Rev Physiol. 2019 Feb 10; 81:309-333. doi:
1146/annurev-physiol-020518-114605. PMID: 30742783;
PMCID: PMC7879424
Ogawa, N., Komura, H., Kuwasako, K. et al. Plasma levels of natriuretic
peptides and development of chronic kidney disease. BMC Nephrol
, 171 (2015). https://doi.org/10.1186/s12882-015-0163-9
Spoletini I, Coats AJS, Senni M, Rosano GMC. Monitoring of
biomarkers in heart failure. European Heart Journal Supplements,
; 21: Supplement: M5- M8 doi.org/10.1093/eurheartj/suz215.
Ellmers, L. J., Scott, N. J., Piuhola, J., Maeda, N., Smithies, O.,
Frampton, C. M., et al. Nprl-regulated gene pathways contribute to
cardiac hypertrophy and fibrosis. J. Mol. Endocrinol. 2007;38: 245-
doi: 10.1677/jme.1.02138.
Hijazi Z, Wallentin L. Natriuretic peptide should be used as a routine
tool for the evaluation of patients with atrial fibrillation. Heart.
;105(5):353-354. doi: 10.1136/heartjnl-2018-314040.
Ali H. Al- Shimmery, Zena AA. Mahdi, Raheem T Al- Mammori,
Thanaa Abdulmahdi
Mokif, Noor S Al-Khafaji. Immunological Study of IFN-y, ICAM-4, and
Vitamin D3
Markers among Gastrointestinal Tumor Patients in Babylon Province,
Iraq. The Asian
Pacific Journal of Cancer Prevention. 2023, 24(1): 253-257
Moyes AJ, Hobbs AJ. C-type Natriuretic Peptide: A Multifaceted
Paracrine Regulator in the Heart and Vasculature. Int J Mol Sci.
May 8;20(9):2281. doi: 10.3390/ijms20092281.
Moyes AJ, Chu SM, Aubdool AA, Dukinfield MS, Margulies KB, Bedi
KC, Hodivala-Dilke K, Baliga RS, Hobbs AJ. C-type natriuretic
peptide coordinates cardiac structure and function. Eur Heart J.
Mar 1;41(9):1006-1020. doi: 10.1093/eurheartj/ehz093.
Surendran K, Simon TC. CNP gene expression is activated by Wnt
signaling and correlates with Wnt4 expression during renal injury.
American Journal of Physiology. Renal Physiology. 2003
Apr;284(4): F653-62. doi: 10.1152/ajprenal.00343.2002.
Prickett TCR, Helen L, Warwick J., et al 2019. Urinary Amino-Terminal
Pro-C-Type Natriuretic Peptide: A Novel Marker of Chronic
Kidney Disease in Diabetes, Clinical Chemistry 2019; 65:306910,
doi: 10.1373/clinchem.2019.306910
Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, Lentini P, de Cal M,
Corradi V, Virzi G, Ronco C. NGAL: a biomarker of acute kidney
injury and other systemic conditions. Int Urol Nephrol. 2010
Mar;42(l):141-50. doi: 10.1007/sll255-009-9608-z.
Guo L, Zhao Y, Yong Z, Zhao W. Evaluation value of neutrophil
gelatinase-associated lipocalin for the renal dysfunction of patients
with chronic kidney disease: A meta-analysis. Aging Med (Milton).
Sep 26;1(2):185-196. doi: 10.1002/agm2.12033. PMID:
; PMCID: PMC6880667.
Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new
marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;
:89-94. doi: 10.1080/00365510802150158. PMID: 18569973;
PMCID: PMC2528839
Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA,
Kalim S, Nigwekar SU, Flood JG, Nixon A, Simonetto DA, Juncos
LA, Karakala N, Wadei HM, Regner KR, Belcher JM, Nadim MK,
Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT; HRSHARMONY study investigators. Urinary NGAL as a Diagnostic
and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A
Prospective Study. Clin Transl Gastroenterol. 2021 May 11;12(5):
e00359. doi: 10.14309/ctg.0000000000000359. PMID: 33979307;
PMCID: PMC8116001
Paul S, Harshaw-Ellis K. Evolving use of biomarkers in the management
of heart failure.Cardiol Rev 2019;27:153-159. doi:
1097/crd.0000000000000224
Karim Abdul-Husseein, Akram Al- Akkam, Karim AH. Liver Function
Abnormalities in COVID-19 Patients and Their Association with
Age and Sex: A Cross-Sectional Study. Archives of Razi Institute.
, 28(1): 453-458.
Nadar SK, Shaikh MM. Biomarkers in routine heart failure clinical care.
Card Fail Rev J 2019; 5: 1- 7. doi: 10.15420/cfr.2018.27.
Takase H, Dohi Y. Kidney function crucially affects B-type natriuretic
peptide (BNP), N-terminal proBNP, and their relationship. Eur J
Clin Invest. 2014;44(3):303-8. doi: 10.111l/eci.12234. Epub 2014
Jan 20. PMID: 24372567.
Srisawasdi P, Vanavanan S, Charoenpanichkit C, Kroll MH. The effect
of renal dysfunction on BNP, NT-proBNP, and their ratio. Am J
Clin Pathol. 2010 Jan;133(l):14-23. doi:
1309/AJCP60HTPGIGFCNK. PMID: 20023254.
Basturk T, Sari O, Koc Y, Eren N, Isleem M, Kara E, Sevinc M, Sakaci T,
Ahbap E, Hasbal NB, Bayrakdar Caglayan F, Unsal A. Prognostic
significance of NGAL in early-stage chronic kidney disease.
Minerva Urol Nefrol. 2017 Jun;69(3):307-312. doi: 10.23736/S0393-
16.02770-3. Epub 2016 Oct 21. PMID: 27768023.
Singh P, Deshwali S, Potey GG, Sharma A. Study of serum sodium and
serum potassium level in chronic renal failure, Int. J. Adv. Res. Biol.
Sci. (2017). 4(11): 103-111103, DOI:
http://dx.doi.org/10.22192/ijarbs.2O17.04.11.013.
Gul A, Yilmaz R, Ozmen ZC, Gumuser R, Demir O, Unsal V.
Assessment of renal function in obese and overweight children with
NGAL and KIM-1 biomarkers. Nutr Hosp. 2020 Jul 13;34(3):436-
English, doi: 10.20960/nh.02651. PMID: 32207310.
Scrutinio D, Passantino A, Guida P, Ammirati E, Oliva F, Sarzi Braga S,
La Rovere MT, Lagioia R, Frigerio M, Di Somma S. Relationship
among body mass index, NT-proBNP, and mortality in
decompensated chronic heart failure. Heart Lung. 2017 MayJun;46(3):172-177. doi: 10.1016/j.hrtlng.2017.01.005. Epub 2017
Feb 8. PMID: 28187908.
Shaikh W, H Mehta J H, Reddy C, Gokhale NS. Clinical significance of
NT-proBNP levels in Chronic Kidney Disease Patients with or
without Heart Failure: An Indian Perspective. Journal of Cardiology
Research and Reports, 2021; 3(1): Doi: 10.31579/2692-9759/012.
Factor-Beta 1 (TGFpi) Levels in Cases with Multiple Myeloma: CaseControl Study among Iraqis. Journal for ReAttach Therapy and
Developmental Diversities. 2023, 5 (2s), 516-523.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
